Program Description:
Clinicians should be informed and stay current about new molecular entities and new indications of drugs for use in everyday practice. This CME/CEU activity is designed to give clinicians a better understanding of the pharmacology, indications, contraindications, benefits/risks, and clinical trials data of a broad spectrum of new agents and those that have been granted a new indication. This activity will allow these health care professionals to make the most up-to-date—and most appropriate—therapeutic decisions for their patients.
INTENDED AUDIENCE:
Physicians, Pharmacists
Activity Objectives:
After participating in this activity, clinicians should be better able to:
- List drug names, mechanisms of action, and pharmacologic properties
- Identify contraindications and precautions that may preclude or condition the drug’s use
- Outline potential adverse drug reactions, drug interactions, and necessary monitoring parameters
- Discuss route of administration, dosing schedule, and dosing formulations
- Compare therapy with other members of the same therapeutic class
- For Pharmacists Only: Provide accurate and appropriate counsel as part of the treatment team
Type of Activity:
Knowledge
|
Credits
|
Type
|
Accreditation Statement
|
Designation Statement
|
|
0.75
|
AMA PRA Category 1 Credit(s)TM
|
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and Haymarket Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
|
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|
|
0.75
|
CE for Pharmacists
|
 Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Postgraduate Institute for Medicine designates this continuing education activity for 0.75 contact hour (0.075 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number (UAN) 0809-9999-12-173-H01-P.
|
Faculty:
Evelyn Hermes-DeSantis, PharmD
Clinical Associate Professor
Ernest Mario School of Pharmacy at Rutgers,
The State University of New Jersey
Director, Drug Information Services
Robert Wood Johnson University Hospital
New Brunswick, NJ
Disclosures:
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) assesses conflicts of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Evelyn Hermes-DeSantis, PharmD, has nothing to disclose.
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The following Haymarket Medical Education planners over the past 12 months: Nick Zittell, Editor; Kathryn Kovalycsik, PharmD, writer; and Lynne Callea, Program Director, have nothing to disclose.
The following PIM planners and managers over the past 12 months: Laura Excell, ND, NP, MS, MA, LPC, NCC; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CCMEP; Jan Schultz, RN, MSN, CCMEP; and Patricia Staples, MSN, NP-C, CCRN, have nothing to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM) and Haymarket Medical Education do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM or Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Accredited Provider:
Jointly sponsored by Postgraduate Institute for Medicine and Haymarket Medical Education
If you have any questions relating to the accreditation of this activity, please contact information@pimed.com.
Commercial Supporter:
There is no commercial support for this activity.
Instructions:
Method of Participation and Request for Credit:
There are no fees for participating and receiving CME/CPE credit for this activity.
During the period of May 31, 2012 through June 1, 2013, participants must:
1) Read the educational objectives and faculty disclosures
2) Study the educational activity
3) Complete the post-test by going to www.myCME.com/MPRjune12 and recording the best answer to each test question.
4) Complete the evaluation form
Medium: Print material – enduring monograph
SYSTEM REQUIREMENTS:
WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution
set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.
MACINTOSH® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20
MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands
of Colors”; Macromedia Flash Player 6 or higher.